⌕
Tilray Brands · TLRY · Nasdaq
Tenet 45 · Mixed
Compare
$2.35+0.43%At closeTenet 45 · Mixed
$2.35+0.01 (+0.43%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Tilray Brands (TLRY) Key Ratios

Valuation, quality, health and growth. Every ratio ranked against its sector peers — the number we score — with its own ten-year record shown beside it for context.

Sources Company filings and market prices Filings and pricesRatios computed How we compute thisNot investment advice
56
VALUE
Fairly priced
in line with its peers
30
QUALITY
Weak
below-peer returns
45
HEALTH
Stable
manageable balance sheet
51
GROWTH
FCF only
growth rates not measurable; scored on FCF margin alone

A weak business at a fair price: value 56, quality 30, health 45, growth 51, each a percentile within Healthcare.

Values are the trailing twelve months where a company files quarterly statements and the figure passes our check against the filings, with balance-sheet ratios from the most recent quarter; otherwise, or where a sector's figure is still under review, the latest fiscal year. Piotroski and the five-year growth rates are fiscal years. Each row names its period.track = where peers land, worse → better (direction-adjusted: right always means better)▏sector median● you are here▲ where today's value sits in the company's own ten fiscal years (context, not scored)hover any metric for its formula
56th pctilein line with its peers
Earnings yield (EBIT/EV)EBIT (operating income) for the latest fiscal year ÷ enterprise value on the current market cap (Greenblatt). The vendor's own earnings yield is net income to common ÷ market cap, a different figure.—Not meaningful: operating income is zero or negative.
P/E—Not meaningful: the company made a loss.
P/B0.2100th pctileMarket cap at the close of Nov 16, 2026 ÷ book equity at Aug 31, 2026 (most recent quarter)
P/FCF—Withheld: the company files no capital-expenditure line, so there is no free cash flow.
EV / EBITDA70.412th pctileown record too shortEnterprise value at the close of Nov 16, 2026 ÷ fiscal 2026 EBITDAFiscal 2026: trailing figures for Healthcare are still under review
45th pctilemanageable balance sheet
Current ratio1.8826th pctileMost recent quarter, Aug 31, 2026
Quick ratioMost recent quarter: How many dollars of cash and money already owed to the company it holds for each dollar of bills due within a year.0.9514th pctileMost recent quarter, Aug 31, 2026
Net debt / EBITDATotal debt (excluding leases) less cash and short-term investments, over EBITDA (operating income plus depreciation and amortisation) from the filed statements. Total debt is short-term plus long-term borrowings; lease liabilities are not included. Long-term investments are not counted as cash. For some companies they include marketable securities held for more than a year.−1.0×78th pctileown record too shortTenet-derived Total debt (excluding leases) less cash and short-term investments, over EBITDA (operating income plus depreciation and amortisation) from the filed statements. Total debt is short-term plus long-term borrowings; lease liabilities are not included. Long-term investments are not counted as cash. For some companies they include marketable securities held for more than a year. Computed by Tenet from the filed statements (formula house-nde.v1), because the data vendor published no value for this year.Fiscal 2026 (May 31, 2026)Fiscal 2026: trailing figures for Healthcare are still under review
Interest coverage—Not meaningful: operating income is zero or negative.
Debt / equity0.1361st pctileMost recent quarter, Aug 31, 2026
30th pctilebelow-peer returns
ROIC−5%49th pctileTTM through Aug 31, 2026
ROE−9%49th pctileTTM through Aug 31, 2026
Gross margin29.1%14th pctileTTM through Aug 31, 2026
Net margin−15.2%27th pctileTTM through Aug 31, 2026
Income quality (CFO/NI)—Not meaningful: the company made a loss.
Piotroski F3 / 931st pctileown record too shortFiscal 2026 (May 31, 2026)
Altman Z−2.210th pctileTTM through Aug 31, 2026
51st pctilegrowth rates not measurable; scored on FCF margin alone
Revenue CAGRThe yearly rate that compounds the earliest fiscal year's revenue into the latest one, over the true number of fiscal years between them (up to five). When the earliest year's revenue is zero or negative, the rate starts from the first later year with at least $10M of revenue, provided at least three years remain.—This growth figure starts in a period outside the history your plan includes.
EPS CAGR—This growth figure starts in a period outside the history your plan includes.
FCF margin—Not reported in the company's filings for this period.
the receipts behind the numbers above
Greenblatt earnings yield—EBIT ÷ EV The vendor's "earningsYield" is NI ÷ market cap, which is not Greenblatt's formula.
ROIC−5%NOPAT ÷ invested capital The vendor's simple ROIC, not its tiny-base roic tag; withheld when a negative EBIT flips its sign.
Interest coverage— Guarded, not faked: we have no interest-expense figure on file for this company, so it's excluded from the ranking instead of rendered as garbage.
Percentiles computed nightly against 439 Healthcare peers from our ingested fundamentals DB · raw statements for corrected metrics. Direction-adjusted: for "lower is better" ratios (P/E, D/E…) the percentile is flipped so right always means better. The percentile is the stock's rank among sector peers, the number that is scored. The triangle marks where the current value (the trailing twelve months or the latest fiscal year, as its row names) sits in the company's own ten fiscal-year record, shown for context and never blended into the score. Computed Nov 17, 2026 · Not investment advice.

What is Tilray Brands' Piotroski F-Score?

Tilray Brands' Piotroski F-Score is 3 of 9 for fiscal 2026.

What is Tilray Brands' Altman Z-Score?

Tilray Brands' Altman Z-Score is −2.2, TTM through Aug 31, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.